BioMap
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $100M
Investors
- 5
About BioMap
Founded in 2020 and based in Beijing, China, BioMap operates as a biotechnology company that focuses on the operation and management of life science platforms. The company was co-founded by the former BV Baidu Ventures bio-intelligence team and its 50 global portfolio companies. It was recognized as the National High-tech Enterprise. Wei Liu, the CEO of the company, graduated from Cambridge University and used to serve as Vice President of Baidu, CEO of Baidu Ventures, and Chairman of Comet Labs, etc. BioMap has branch offices in Beijing, HongKong, and the Silicon Valley. In 2023, the company cooperated with Sanofi. BioMap mainly engages in the operation and management of life science platforms. Its biocomputing platform utilizes algorithms, smart sensors, smart chips, micro-nano robots, and other AI technologies to solve life science problems. The platform provides services such as data collection, multidimensional data mining and analysis, computational drug design, and high-throughput automated experimental validation. The company also engages in the development of AI drugs, such as single-cell precision medicine diagnostic and therapeutic products. The company generates revenue by operating life science platforms. The company plans to set up a biocomputing innovation center, InnoHub, in Hong Kong. The company will continue to increase its investment in Hong Kong over the next 3 years.
Who invested in BioMap
5 investors across 1 round
See all investors in BioMap
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 30, 2021
Amount
$100M
Investors
Questions about BioMap
Who invested in BioMap?
BioMap has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioMap raised?
BioMap has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioMap last raise money?
BioMap's most recent round on record is a Series A, in Jul 2021.
What does BioMap do?
Founded in 2020 and based in Beijing, China, BioMap operates as a biotechnology company that focuses on the operation and management of life science platforms.
Where is BioMap headquartered?
BioMap is headquartered in Beijing, China.
Which VCs invest in companies like BioMap?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BioMap's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BioMap? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.